The use over time of statins in coronary patients in an Italian tertiary referral center

Italian Heart Journal

Volumn 2, Issue 11, 2001, Pages 848-853

  Gaspardone, A ^a   Proietti, I ^a   Altamura, L ^a   Tomai, F ^a   Versaci, F ^a   Crea, F ^a   Chiariello, L ^a   Gioffre P A ^a  

^a EUROPEAN HOSPITAL   (Italy)

Author keywords

Coronary artery disease; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA ANALYSIS; DEMOGRAPHY; DRUG EFFICACY; FEMALE; HOSPITAL ADMISSION; HUMAN; ITALY; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; MEDICAL SPECIALIST; PATIENT REFERRAL; PRESCRIPTION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; TIME;

AGED; ANTICHOLESTEREMIC AGENTS; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; DRUG UTILIZATION REVIEW; FATTY ACIDS, MONOUNSATURATED; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDOLES; ITALY; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRAVASTATIN; PYRROLES; RETROSPECTIVE STUDIES; RISK FACTORS; SIMVASTATIN;

EID: 0035670203     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
2. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
4. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
5. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
6. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension
7. Together with Members of the Task Force. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of the European Society of Cardiology and other Prevention
8. Rationale for and outline of the recommendations of the Working Group on Hypercholesterolemia and Other Dyslipidemias: Interim report
9. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: Executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on (Committee on Management of Patients with Chronic Stable Angina)
10. The prevention of coronary disease in clinical practice. The recommendations of the Second Joint Task Force of European Societies on the Prevention of Coronary Pathology
11. Physician non-compliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines
12. Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease
13. Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: Data from the National Registry of Myocardial Infarction 3
14. Are statins anti-inflammatory? Issues in the design and conduct of the pravastatin inflammation C-reactive protein evaluation
15. The evolving role of statins in the management of atherosclerosis
16. C-reactive protein as a clinical marker of risk
17. Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease
18. The World Health Organization MONICA project (MONItoring trends and determinants in Cardiovascular disease): A major international collaboration
19. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
20. Effects of standardization with the new international reference preparation for proteins in human serum on method comparability and reference values
21. Statistica medica. Metodi statistici per la ricerca in medicina
22. Effect of statins on risk of coronary disease: A meta-analysis of randomized controlled trials
23. Non-lipid-lowering effects of statins on atherosclerosis
24. Effect of statins on C-reactive protein in patients with coronary artery disease
25. Long-term effects of pravastatin on plasma concentration of C-reactive protein
26. Evidenza di infiammazione e rischio di morte nello Scandinavian Simvastatin Survival Study (4S)
27. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events